What This Means
This research suggests that men living with HIV who also use stimulant drugs (such as amphetamines or cocaine) may have higher levels of a blood marker called high-sensitivity cardiac troponin T (hs-cTnT) compared to men without HIV who do not use stimulants. Troponin T is a protein released when heart muscle cells are damaged or stressed, and elevated levels — even at subclinical (below the threshold of obvious disease) amounts — can signal early or ongoing injury to the heart. In this study of 72 men in South Florida, those with both HIV and stimulant use were about 7.5 times more likely to have detectable troponin in their blood, and had higher concentrations of it, after accounting for age and tobacco use. Additionally, among those with urine toxicology data available, higher levels of amphetamine metabolites were strongly correlated with higher troponin levels, suggesting a possible dose-response relationship.
This research matters because people living with HIV already face a higher risk of heart disease than those without HIV, and stimulant use is disproportionately common in some HIV-affected communities. Identifying early signs of heart injury — before symptoms appear — could be important for understanding and eventually addressing this elevated risk. However, the authors are careful to note that elevated troponin can reflect many different processes (acute, subacute, or chronic), and that this study was small, limited to cisgender men in one region, and designed as a preliminary, exploratory investigation. These findings should be considered hypothesis-generating and will need to be confirmed in larger, more diverse studies before broader conclusions can be drawn.